Currently out of the existing stock ratings of Ling Wang, 22 are a BUY (95.65%), 1 are a HOLD (4.35%).

Ling Wang

Work Performance Price Targets & Ratings Chart

Analyst Ling Wang works with a stock forecast success ratio of 32.14% fulfilled within 253.86 days on average. Previously, Ling Wang worked at OPPENHEIMER.

Ling Wang’s has documented 55 price targets and ratings displayed on 7 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.

Wall Street Analyst Ling Wang

Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for IMGN (IMMUNOGEN) at 8/27/2010. The price target of $9 was fulfilled within 110 days with a profit of $3.84 (74.42%) receiving and performance score of 6.77.

Average potential price target upside

IMGN ImmunoGen RLYP Relypsa RMTI Rockwell Medical DQ Daqo New Energy Corp ADR LJPC La Jolla Pharmaceutical Co MACK Merrimack Pharmaceuticals TCON TRACON Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

31

$-0.23 (-0.74%)

6

2 months 20 days ago

6/6 (100%)

$1.78 (6.09%)

612

Hold

27

2 months 23 days ago

4/4 (100%)

$9.83 (57.25%)

134

Hold

31

$-0.23 (-0.74%)

26

2 months 23 days ago

4/4 (100%)

$1.68 (5.73%)

224

Hold

31

$-0.23 (-0.74%)

7

2 months 23 days ago

2/2 (100%)

$1.68 (5.73%)

35

Hold

31

$-0.23 (-0.74%)

4

2 months 23 days ago

6/6 (100%)

$1.68 (5.73%)

1362

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ling Wang?

On 2009

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?